24 results
PRER14A
VTAK
Catheter Precision Inc.
3 Nov 22
Preliminary revised proxy
9:55pm
candidates.
Catheter may use independent clinical investigators and other third-party service providers to conduct and/or oversee the clinical trials
DEFA14A
VTAK
Catheter Precision Inc.
27 Sep 22
Additional proxy soliciting materials
8:07am
of Fatih Ayoglu to the newly created position of Business Development Manager—EMEA. Mr. Ayoglu will oversee clinical and sales development of Catheter
425
VTAK
Catheter Precision Inc.
27 Sep 22
Business combination disclosure
8:07am
of Fatih Ayoglu to the newly created position of Business Development Manager—EMEA. Mr. Ayoglu will oversee clinical and sales development of Catheter
8-K
EX-99.1
VTAK
Catheter Precision Inc.
27 Sep 22
Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA
8:05am
to the newly created position of Business Development Manager—EMEA. Mr. Ayoglu will oversee clinical and sales development of Catheter Precision products
PREM14A
y3fnnfeh iaa63qwcac
23 Sep 22
Preliminary proxy related to merger
5:28pm
DEFA14A
5nxl3qqsvwvi2hk
9 Sep 22
Additional proxy soliciting materials
8:50pm
8-K
EX-99.8
lztzd enu0is3n
9 Sep 22
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
8:12pm
424B1
hbt3l5jmh 41v476g
7 Feb 22
Prospectus with pricing info
6:02am
PRE 14A
s957tv5559x0io63udx
17 Aug 20
Preliminary proxy
4:15pm
DEF 14A
1c4g9 uyz6lct1v
19 Apr 19
Definitive proxy
12:16pm
10-K
duoszrb
15 Mar 19
Annual report
12:00am
8-K
EX-99.1
4ty5d9hjosfc2982
14 Mar 19
Ra Medical Systems Reports 2018 Fourth Quarter and Full Year Financial Results
4:05pm